Kangmei Pharma | 600518 - Assets

Stock Price
1.88
Daily Change
0.01 0.53%
Monthly
-1.57%
Yearly
-14.93%
Q1 Forecast
1.84

Kangmei Pharma reported CNY13.68B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Genomma Lab Internacional MXN 23.83B 226.23M Dec/2025
Hypermarcas BRL 25.15B 916.05M Sep/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Jiangsu Hengrui CNY 68.33B 5.43B Sep/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Moderna USD 12.34B 203M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Revvity USD 12.17B 29.46M Dec/2025
Sh Fosun Pharma CNY 118.12B 707.2M Sep/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Viatris USD 37.19B 727.3M Dec/2025
Wuxi Apptec CNY 94.61B 10.78B Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025